Medline Inc
MDLN
206 hedge funds and large institutions have $29.9B invested in Medline Inc in 2025 Q4 according to their latest regulatory filings, with 206 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
90.58% more ownership
Funds ownership: 0% → 90.58% (+91%)
70% less call options, than puts
Call options by funds: $23.6M | Put options by funds: $77.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$9.09B |
| 2 |
Blackstone Inc
New York
|
+$6.04B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.11B |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$798M |
| 5 |
Morgan Stanley
New York
|
+$640M |
Top Sellers
MDLN Hedge Fund Activity: Q4 2025 in Review
206 of the 8,287 institutional investors tracked by Wall St. Rank reported a position in Medline Inc (MDLN) for Q4 2025, worth a combined $29.9B.
Buyers outnumbered sellers: 206 funds opened new MDLN positions and 0 closed out — a net gain of 206 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Carlyle Group, opening a new position worth an estimated $9.09B.
- 206 institutional investors held Medline Inc (MDLN) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $29.9B of Medline Inc stock for Q4 2025.
- 206 funds opened new Medline Inc positions in Q4 2025 and 0 closed out, a net change of +206 holders.
- The largest Medline Inc buyer in Q4 2025 was Carlyle Group, an estimated $9.09B added.
Based on aggregated 13F filings for Q4 2025.